With more clinical trials for different outcomes, treatment indications for GLP-1 medications could eventually be expanded beyond their current approvals for diabetes and weight loss.stay tuned
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes
Available in three concentrations to match your treatment phase
If youre interested in learning more about tirzepatide or exploring your options for medical weight management, contact En Vogue IV Therapy & Wellness today to schedule your personalized consultation
The right electrolyte mix can ease common GLP-1 side effects, support energy levels, and keep your body in balanceeven when meals are small or infrequent
The symptoms of defects in fatty acid metabolism and disorders of the carnitine cycle can vary widely and may be quite non-specific